Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 3
Submit an article Journal homepage
1,084
Views
10
CrossRef citations to date
0
Altmetric
Review

Bendamustine for the treatment of multiple myeloma in first-line and relapsed–refractory settings: a review of clinical trial data

Antonio PalumboDepartment of Hematology, University of Turin, Turin, ItalyCorrespondence[email protected]
,
Massimo OffidaniClinica di Ematologia, AUO Ospedali Riuniti di Ancona, Ancona, Italy
,
Francesca PatriarcaDepartment of Hematology, DISM, University of Udine, Udine, Italy
,
Maria Teresa PetrucciDepartment of Cellular Biotechnology and Hematology, Sapienza University of Rome, Rome, Italy
&
Michele CavoInstitute of Hematology and Medical Oncology “Seràgnoli”, Bologna University School of Medicine, University Hospital S. Orsola, Bologna, Italy
Pages 559-567 | Received 17 Jan 2014, Accepted 08 Apr 2014, Published online: 27 Jun 2014

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.